Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 21, 2013
Pharmacy Choice - Pharmaceutical News - House approves GOP bill repealing medical tax - May 21, 2013

Pharmacy News Article

 6/7/12 - House approves GOP bill repealing medical tax

WASHINGTON The House has shrugged off a veto threat and passed legislation repealing a tax on companies that produce many medical devices sold in the United States.

Lawmakers approved the measure 270-146. Majority Republicans won support from three-dozen Democrats representing states where medical equipment makers have a heavy presence like Minnesota and Pennsylvania.

Republicans and device makers hoped Thursday's vote would build pressure on the Senate to approve the bill. But Democrats who run that chamber have said they have no plans to consider yet another GOP effort to weaken President Barack Obama's health care law.

The tax was created by that law to help finance it. It would levy a 2.3 percent tax on makers of medical devices sold in the U.S., while exempting consumer items like eyeglasses.

THIS IS A BREAKING NEWS UPDATE. Check back soon for further information. AP's earlier story is below.

Republicans shrugged off a veto threat and began pushing legislation through the House on Thursday that would repeal a tax on companies that produce many medical devices sold in the United States.

Passage was assured because more than half of the 435-member House was sponsoring the measure. Republicans assailing the tax as a job-killer received support from some Democrats representing states where medical equipment makers have a heavy presence, including Minnesota, Pennsylvania and Massachusetts.

The 2.3 percent tax, set to take effect in January, is aimed at makers of equipment such as X-ray machines and replacement hips that is sold in the U.S. and used chiefly by doctors and hospitals. It does not apply to consumer goods such as bandages and hearing aids. The tax is projected to bring in $29 billion over the next decade for the government.

"Why in the world would we want to take another $29 billion worth of innovations out of our future and out of our health care industry and put it in the hands of this government?" said Rep. Tim Scott, R-S.C.

The measure's prospects are grim in the Senate, where Democratic leaders do not plan to bring it up.

The tax was enacted in 2010 as part of President Barack Obama's health care overhaul. It is intended to help pay for that law's expansion of insurance coverage. Democrats said the GOP effort to rescind the tax was another attempt to weaken and kill the law, which Republicans oppose, and said GOP claims that the tax would kill jobs were exaggerated.

"Here we are again with another bill to repeal the Affordable Care Act," said Rep. Jared Polis, D-Colo., using the health care law's formal name.

Since the law's enactment, the GOP-led House has voted numerous times to cut some subsidies for patients, trim financing for a preventive health fund and make other reductions in the statute's scope, including some measures that have been signed by Obama.

Device manufacturers want to kill the tax before it kicks in. On Wednesday, more than 700 associations and companies, including AdvaMed and the Medical Device Manufacturers Association, the industry's chief trade groups, wrote to House leaders urging them to erase the tax.

"If this tax is not repealed, it will continue to force affected companies to consider cutting manufacturing operations, research and development, and employment levels to recoup the lost earnings due to the tax," they wrote.

The U.S. Chamber of Commerce said the tax would "lead to increased health care costs, undercutting one of the primary goals of health care reform."

The medical device industry employs around 400,000 people in the U.S. and has annual sales of around $130 billion.

In their letter threatening a veto, White House officials said the health care law would give the medical device industry 30 million new potential customers who will gain health insurance. Industry officials deny that, saying the elderly patients who use many of their products are already covered by Medicare.

The legislation has been combined with two other provisions. One would let people recover up to $500 from their tax-favored health flexible spending accounts if they don't use all the money for medical bills. They currently lose any unspent funds in such accounts.

The other would let people use money from some tax-advantaged health savings accounts for over-the-counter drugs.

The overall bill would cost $37 billion over 10 years.

It would be more than paid for by eliminating limits on the money the government could recover if it gives lower-earning people subsidies for buying health insurance that are higher than they qualify for. When that part of the health care law takes effect in two years, the subsidies will be paid in advance and the government estimates it will end up making billions of dollars in overpayments.

That provision would save a projected $44 billion for the government over the decade, meaning that overall the legislation would save $7 billion. White House officials say removing the limits on the subsidies the government recovers is essentially a tax increase and that it would discourage people from signing up for coverage.

In its letter, White House officials wrote that the bill "would fund tax breaks for industry by raising taxes on middle-class and low-income families."

-

Online:

Medical Device Manufacturers Association: http://www.medicaldevices.org

Information on H.RES 679 can be found at http://thomas.loc.gov/home/thomas



(c) 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
May 21: Update on the Treatment for Child Psychiatric Disorders
Last Chance
May 22: Drug & Safety During Pregnancy & Lactation
May 23: Serotonin Syndrome: Etiology, Pathology & Treatment
May 29: A Patient-Centered Approach to Chronic Pain Management
May 30: Drug Addiction: Underlying Factors & Treatment Options
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415